Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
|
|
Merck & Co., Inc. (MRK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2022 2021 % Change 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year 4Q Full Year Sales $ 15,901 $ 14,593 $ 14,959 $ 13,830 $ 59,283 $ 10,627 $ 11,402 $ 13,154 $ 13,521 $ 48,704 2 % 22 % Costs, Expenses and Other Cost of sales 5,380 4,216 3,934 3,881 17,411 3,199 3,104 3,450 3,873 13,626 0 % 28 % Selling, general and administrative 2,323 2,512 2,520 2,687 10,042 2,187 2,281 2,336 2,830 9,634 -5 % 4 % Research and development 2,576 2,798 4,399 3,775 13,548 2,412 4,321 2,445 3,068 12,245 23 % 11 % Restructuring costs 53 142 94 49 337 297 82 107 174 661 -72 % -49 % Other expense, net 708 438 429 1,501 -77 % * Income from Continuing Operations Before Taxes 4,861 4,487 3,583 3,513 16,444 2,987 1,717 5,266 3,909 13,879 -10 % 18 % In..." |
|
| 07/28/2022 |
8-K
| Quarterly results |
| 04/28/2022 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces First-Quarter 2022 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2022 2021 % Change 1Q 1Q 2Q 3Q 4Q Full Year 1Q Sales $ 15,901 $ 10,627 $ 11,402 $ 13,154 $ 13,521 $ 48,704 50 % Costs, Expenses and Other Cost of sales 5,380 3,199 3,104 3,450 3,873 13,626 68 % Selling, general and administrative 2,323 2,187 2,281 2,336 2,830 9,634 6 % Research and development 2,576 2,412 4,321 2,445 3,068 12,245 7 % Restructuring costs 53 297 82 107 174 661 -82 % Other expense, net 708 * Income from Continuing Operations Before Taxes 4,861 2,987 1,717 5,266 3,909 13,879 63 % Income Tax Provision 554 238 503 695 85 1,521 Net Income from Continuing Operations 4,307 2,749 1,214 4,571 3,824 12,358 57 % Less: Net Income Attributable to Noncontrolling Interests 4 1 4 4 13 Net Income from Continuing Operations..." |
|
| 02/03/2022 |
8-K
| Quarterly results |
| 10/28/2021 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Third-Quarter 2021 Financial Results",
"CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2021 2020 % Change 1Q 2Q 3Q Sep YTD 1Q 2Q 3Q Sep YTD 4Q Full Year 3Q Sep YTD Sales $ 10,627 $ 11,402 $ 13,154 $ 35,183 $ 10,288 $ 9,353 $ 10,929 $ 30,570 $ 10,948 $ 41,518 20% 15% Costs, Expenses and Other Cost of sales 3,199 3,104 3,450 9,752 2,829 2,747 3,013 8,589 5,029 13,618 15% 14% Selling, general and administrative 2,187 2,281 2,336 6,804 2,191 2,085 2,060 6,336 2,619 8,955 13% 7% Research and development 2,412 4,321 2,445 9,177 2,175 2,085 3,349 7,609 5,788 13,397 -27% 21% Restructuring costs 297 82 107 487 70 82 113 265 310 575 -5% 84% Other expense, net 62 44% 58% Income from Continuing Operations Before Taxes 2,987 1,717 5,266 9,970 2,961 2,741 2,706 8,408 5,863 95% 19% Income Tax Provision 238 503 695 1,436 495 396 380 1,27..." |
|
| 07/29/2021 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Second-Quarter 2021 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2021 2020 % Change 1Q 2Q June YTD 1Q 2Q June YTD 3Q 4Q Full Year 2Q June YTD Sales $ 10,627 $ 11,402 $ 22,029 $ 10,288 $ 9,353 $ 19,641 $ 10,929 $ 10,948 $ 41,518 22 % 12 % Costs, Expenses and Other Cost of sales 3,199 3,104 6,303 2,829 2,747 5,576 3,013 5,029 13,618 13 % 13 % Selling, general and administrative 2,187 2,281 4,468 2,191 2,085 4,276 2,060 2,619 8,955 9 % 4 % Research and development 2,412 4,321 6,732 2,175 2,085 4,260 3,349 5,788 13,397 * 58 % Restructuring costs 297 82 380 70 82 152 113 310 575 0 % * Other expense, net 62 -73 % 72 % Income from Continuing Operations Before Taxes 2,987 1,717 4,704 2,961 2,741 5,702 2,706 5,863 -37 % -18 % Income Tax Provision 238 503 741 495 396 891 380 69 1,340 Net Incom..." |
|
| 02/04/2021 |
8-K
| Quarterly results |
| 10/27/2020 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Third-Quarter 2020 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2020 2019 % Change 1Q 2Q 3Q Sep YTD 1Q 2Q 3Q Sep YTD 4Q Full Year 3Q Sep YTD Sales $ 12,057 $ 10,872 $ 12,551 $ 35,479 $ 10,816 $ 11,760 $ 12,397 $ 34,972 $ 11,868 $ 46,840 1 % 1 % Costs, Expenses and Other Cost of sales 3,312 3,159 3,481 9,952 3,052 3,401 3,990 10,443 3,669 14,112 -13 % -5 % Selling, general and administrative 2,555 2,378 2,450 7,383 2,425 2,712 2,589 7,726 2,888 10,615 -5 % -4 % Research and development 2,209 2,123 3,390 7,721 1,931 2,189 3,204 7,324 2,548 9,872 6 % 5 % Restructuring costs 72 83 114 269 153 59 232 444 194 638 -51 % -39 % Other expense, net 71 188 140 35 362 139 * * Income Before Taxes 3,838 3,519 3,428 10,784 3,067 3,259 2,347 8,673 2,792 11,464 46 % 24 % Taxes on Income 619 509 483 1,6..." |
|
| 07/31/2020 |
8-K
| Quarterly results |
| 04/28/2020 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces First-Quarter 2020 Financial Results",
"MERCK & CO., INC. GAAP TO NON-GAAP RECONCILIATION FIRST QUARTER 2019 Table 2b GAAP Acquisition and Divestiture-Related Costs Restructuring Costs Certain Other Items Adjustment Subtotal Non-GAAP Cost of sales $ 3,052 413 34 447 $ 2,605 Selling, general and administrative 2,425 2,426 Research and development 1,931 1,962 Restructuring costs 153 153 153 - Other expense, net 188 167 167 21 Income Before Taxes 3,067 3,802 Income Tax Provision 205 627 Net Income 2,862 293 3,175 Less: Net Income Attributable to Noncontrolling Interests - Net Income Attributable to Merck & Co., Inc. 2,915 293 3,175 Earnings per Common Share Assuming Dilution $ 1.12 0.11 $ 1.22 Tax Rate 6.7 % 16.5 % Only the line items that are affected by non-GAAP adjustments are shown. Merck is providing certain non-GAA..." |
|
| 02/05/2020 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results",
"MERCK & CO., INC. FRANCHISE / KEY PRODUCT SALES FULL YEAR 2019 Table 3b Global U.S. International Full Year 2019 Full Year 2018 % Change Full Year 2019 Full Year 2018 % Change Full Year 2019 Full Year 2018 % Change TOTAL SALES $ 46,840 $ 42,294 11 $ 20,325 $ 18,212 12 $ 26,515 $ 24,083 10 PHARMACEUTICAL 41,751 37,689 11 18,759 16,608 13 22,992 21,081 9 Oncology Keytruda 11,084 7,171 55 6,305 4,150 52 4,779 3,021 58 Alliance Revenue - Lynparza 444 187 137 269 127 112 176 61 190 Alliance Revenue - Lenvima 404 149 171 239 95 152 165 54 * Emend 388 522 -26 183 312 -41 205 210 -2 Vaccines Gardasil / Gardasil 9 3,737 3,151 19 1,831 1,873 -2 1,905 1,279 49 ProQuad / M-M-R II / Varivax 2,275 1,798 27 1,683 1,430 18 592 368 61 Pneumovax 23 926 907 2 679 627 8 247 281 -12 RotaTeq 791 728 9 506 496 ...",
"Merck to Focus on Key Growth Pillars Through Spinoff of Women’ s Health, Trusted Legacy Brands and Biosimilars Products into New Company NewCo to be a Leading Women’ s Health Company; Represents Total Revenue of Approximately $6.5 Billion for Merck in 2020" |
|
| 10/29/2019 |
8-K
| Quarterly results |
| 07/30/2019 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Second-Quarter 2019 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2019 2018 % Change 1Q 2Q June YTD 1Q 2Q June YTD 3Q 4Q Full Year 2Q June YTD Sales $ 10,816 $ 11,760 $ 22,575 $ 10,037 $ 10,465 $ 20,502 $ 10,794 $ 10,998 $ 42,294 12 % 10 % Costs, Expenses and Other Cost of sales 3,052 3,401 6,453 3,184 3,417 6,601 3,619 3,289 13,509 — -2 % Selling, general and administrative 2,425 2,712 5,138 2,508 2,508 5,016 2,443 2,643 10,102 8 % 2 % Research and development 1,931 2,189 4,119 3,196 2,274 5,470 2,068 2,214 9,752 -4 % -25 % Restructuring costs 153 59 212 95 228 323 171 138 632 -74 % -34 % Other expense, net 188 140 327 110 * * Income Before Taxes 3,067 3,259 6,326 1,345 2,086 3,432 2,665 2,604 8,701 56 % 84 % Taxes on Income 205 615 820 604 370 975 707 826 2,508 Net Income 2,862 2,644..." |
|
| 04/30/2019 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces First-Quarter 2019 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2019 2018 % Change 1Q 1Q 2Q 3Q 4Q Full Year 1Q Sales $ 10,816 $ 10,037 $ 10,465 $ 10,794 $ 10,998 $ 42,294 8 % Costs, Expenses and Other Cost of sales 3,052 3,184 3,417 3,619 3,289 13,509 -4 % Selling, general and administrative 2,425 2,508 2,508 2,443 2,643 10,102 -3 % Research and development 1,931 3,196 2,274 2,068 2,214 9,752 -40 % Restructuring costs 153 95 228 171 138 632 61 % Other expense, net 188 110 * Income Before Taxes 3,067 1,345 2,086 2,665 2,604 8,701 * Taxes on Income 205 604 370 707 826 2,508 Net Income 2,862 741 1,716 1,958 1,778 6,193 * Less: Net Income Attributable to Noncontrolling Interests 5 9 8 Net Income Attributable to Merck & Co., Inc. $ 2,915 $ 736 $ 1,707 $ 1,950 $ 1,827 $ 6,220 * Earnings pe..." |
|
| 02/01/2019 |
8-K
| Quarterly results |
| 10/25/2018 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Third-Quarter 2018 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2018 2017 % Change 1Q 2Q 3Q Sep YTD 1Q 2Q 3Q Sep YTD 4Q Full Year 3Q Sep YTD . . Sales $ 10,037 $ 10,465 $ 10,794 $ 31,296 $ 9,434 $ 9,930 $ 10,325 $ 29,689 $ 10,433 $ 40,122 5 % 5 % Costs, Expenses and Other Materials and production 3,184 3,417 3,619 10,220 3,049 3,116 3,307 9,472 3,440 12,912 9 % 8 % Marketing and administrative 2,508 2,508 2,443 7,459 2,472 2,500 2,459 7,432 2,643 10,074 -1 % — Research and development 3,196 2,274 2,068 7,538 1,830 1,782 4,413 8,024 2,314 10,339 -53 % -6 % Restructuring costs 95 228 171 494 151 166 153 470 306 776 12 % 5 % Other expense, net -17 % 46 % Income Before Taxes 1,345 2,086 2,665 6,097 2,003 2,439 200 4,642 1,879 6,521 * 31 % Taxes on Income 604 370 707 1,682 447 488 251 ...",
"Merck Announces Increased Fourth-Quarter Dividend and $10 Billion Share Repurchase Authorization" |
|
| 07/27/2018 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Second-Quarter 2018 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2018 2017 % Change 1Q 2Q June YTD 1Q 2Q June YTD 3Q 4Q Full Year 2Q June YTD Sales $ 10,037 $ 10,465 $ 20,502 $ 9,434 $ 9,930 $ 19,365 $ 10,325 $ 10,433 $ 40,122 5 % 6 % Costs, Expenses and Other Materials and production 3,184 3,417 6,601 3,049 3,116 6,165 3,307 3,440 12,912 10 % 7 % Marketing and administrative 2,508 2,508 5,016 2,472 2,500 4,972 2,459 2,643 10,074 — 1 % Research and development 3,196 2,274 5,470 1,830 1,782 3,612 4,413 2,314 10,339 28 % 51 % Restructuring costs 95 228 323 151 166 317 153 306 776 37 % 2 % Other expense, net -34 % * Income Before Taxes 1,345 2,086 3,432 2,003 2,439 4,442 200 1,879 6,521 -14 % -23 % Taxes on Income 604 370 975 447 488 935 251 2,917 4,103 Net Income 741 1,716 2,457 1,556..." |
|
| 05/01/2018 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces First-Quarter 2018 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2018 2017 % Change 1Q 1Q 2Q 3Q 4Q Full Year 1Q Sales $ 10,037 $ 9,434 $ 9,930 $ 10,325 $ 10,433 $ 40,122 6 % Costs, Expenses and Other Materials and production 3,184 3,049 3,116 3,307 3,440 12,912 4 % Marketing and administrative 2,508 2,472 2,500 2,459 2,643 10,074 1 % Research and development 3,196 1,830 1,782 4,413 2,314 10,339 75 % Restructuring costs 95 151 166 153 306 776 -37 % Other expense, net * Income Before Taxes 1,345 2,003 2,439 200 1,879 6,521 -33 % Taxes on Income 604 447 488 251 2,917 4,103 Net Income 741 1,556 1,951 2,418 -52 % Less: Net Income Attributable to Noncontrolling Interests 5 5 5 5 8 24 Net Income Attributable to Merck & Co., Inc. $ 736 $ 1,551 $ 1,946 $ $ $ 2,394 -53 % Earnings per Common S..." |
|
| 02/02/2018 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Fourth-Quarter and Full-Year 2017 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2017 2016 % Change 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year 4Q Full Year Sales $ 9,434 $ 9,930 $ 10,325 $ 10,433 $ 40,122 $ 9,312 $ 9,844 $ 10,536 $ 10,115 $ 39,807 3 % 1 % Costs, Expenses and Other Materials and production 3,015 3,080 3,274 3,406 12,775 3,572 3,578 3,409 3,332 13,891 2 % -8 % Marketing and administrative 2,411 2,438 2,401 2,580 9,830 2,318 2,458 2,393 2,593 9,762 -1 % 1 % Research and development 1,796 1,749 4,383 2,055 9,982 1,659 2,151 1,664 4,650 10,124 -56 % -1 % Restructuring costs 151 166 153 306 776 91 134 161 265 651 15 % 19 % Other expense, net 58 58 12 48 19 22 631 720 * -98 % Income Before Taxes 2,003 2,439 200 2,105 6,747 1,624 1,504 2,887 4,659 * 45 % Income Tax Provision 447 488 251 2,96..." |
|
| 10/27/2017 |
8-K
| Quarterly results |
| 07/28/2017 |
8-K
| Form 8-K - Current report: |
| 05/02/2017 |
8-K
| Form 8-K - Current report |
| 02/02/2017 |
8-K
| Form 8-K - Current report |
| 10/25/2016 |
8-K
| Form 8-K - Current report |
| 07/29/2016 |
8-K
| Form 8-K - Current report |
| 05/05/2016 |
8-K
| Form 8-K - Current report |
| 02/03/2016 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Fourth-Quarter and Full-Year 2015 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2015 2014 % Change 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year 4Q Full Year Sales $ 9,425 $ 9,785 $ 10,073 $ 10,215 $ 39,498 $ 10,264 $ 10,934 $ 10,557 $ 10,482 $ 42,237 -3 % -6 % Costs, Expenses and Other Materials and production 3,569 3,754 3,761 3,850 14,934 3,903 4,893 4,223 3,749 16,768 3 % -11 % Marketing and administrative 2,601 2,624 2,472 2,615 10,313 2,734 2,973 2,975 2,924 11,606 -11 % -11 % Research and development 1,737 1,670 1,500 1,797 6,704 1,574 1,664 1,659 2,283 7,180 -21 % -7 % Restructuring costs 82 191 113 233 619 125 163 376 349 1,013 -33 % -39 % Other expense, net 55 739 905 1,527 * * Income Before Taxes 1,381 807 2,397 815 5,401 2,091 1,891 1,490 11,811 17,283 -93 % -69 % Income Tax Provision 423 ..." |
|
| 10/27/2015 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Third-Quarter 2015 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2015 2014 % Change 1Q 2Q 3Q Sep YTD 1Q 2Q 3Q Sep YTD 4Q Dec YTD 3Q Sep YTD Sales $ 9,425 $ 9,785 $ 10,073 $ 29,283 $ 10,264 $ 10,934 $ 10,557 $ 31,755 $ 10,482 $ 42,237 -5 % -8 % Costs, Expenses and Other Materials and production 3,569 3,754 3,761 11,084 3,903 4,893 4,223 13,019 3,749 16,768 -11 % -15 % Marketing and administrative 2,601 2,624 2,472 7,698 2,734 2,973 2,975 8,681 2,924 11,606 -17 % -11 % Research and development 1,737 1,670 1,500 4,906 1,574 1,664 1,659 4,897 2,283 7,180 -10 % — Restructuring costs 82 191 113 386 125 163 376 664 349 1,013 -70 % -42 % Other expense, net 55 739 624 2 % * Income Before Taxes 1,381 807 2,397 4,585 2,091 1,891 1,490 5,472 11,811 17,283 61 % -16 % Income Tax Provision 423 119 ..." |
|
| 07/28/2015 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Second-Quarter 2015 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2015 2014 % Change 1Q 2Q June YTD 1Q 2Q June YTD 3Q 4Q Dec YTD 2Q June YTD Sales $ 9,425 $ 9,785 $ 19,210 $ 10,264 $ 10,934 $ 21,198 $ 10,557 $ 10,482 $ 42,237 -11 % -9 % Costs, Expenses and Other Materials and production 3,569 3,754 7,323 3,903 4,893 8,796 4,223 3,749 16,768 -23 % -17 % Marketing and administrative 2,601 2,624 5,226 2,734 2,973 5,707 2,975 2,924 11,606 -12 % -8 % Research and development 1,737 1,670 3,407 1,574 1,664 3,238 1,659 2,283 7,180 — 5 % Restructuring costs 82 191 273 125 163 288 376 349 1,013 17 % -5 % Other expense, net 55 739 793 * * Income Before Taxes 1,381 807 2,188 2,091 1,891 3,982 1,490 11,811 17,283 -57 % -45 % Income Tax Provision 423 119 542 360 218 648 4,484 5,349 Net Income 958 6..." |
|
| 04/28/2015 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces First-Quarter 2015 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2015 2014 % Change 1Q 1Q 2Q 3Q 4Q Dec YTD 1Q Sales $ 9,425 $ 10,264 $ 10,934 $ 10,557 $ 10,482 $ 42,237 -8 % Costs, Expenses and Other Materials and production 3,569 3,903 4,893 4,223 3,749 16,768 -9 % Marketing and administrative 2,601 2,734 2,973 2,975 2,924 11,606 -5 % Research and development 1,737 1,574 1,664 1,659 2,283 7,180 10 % Restructuring costs 82 125 163 376 349 1,013 -34 % Other expense, net 55 * Income Before Taxes 1,381 2,091 1,891 1,490 11,811 17,283 -34 % Income Tax Provision 423 360 648 4,484 5,349 Net Income 958 1,731 2,033 842 7,327 11,934 -45 % Less: Net Income Attributable to Noncontrolling Interests 5 26 29 11 14 Net Income Attributable to Merck & Co., Inc. $ 953 $ 1,705 $ 2,004 $ 895 $ 7,316 $ 11..." |
|
| 02/04/2015 |
8-K
| Quarterly results |
| 10/27/2014 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Third-Quarter 2014 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2014 2013 % Change 1Q 2Q 3Q Sep YTD 1Q 2Q 3Q Sep YTD 4Q Full Year 3Q Sep YTD Sales $ 10,264 $ 10,934 $ 10,557 $ 31,755 $ 10,671 $ 11,010 $ 11,032 $ 32,713 $ 11,319 $ 44,033 -4 % -3 % Costs, Expenses and Other Materials and production 3,903 4,893 4,223 13,019 3,959 4,284 4,104 12,347 4,607 16,954 3 % 5 % Marketing and administrative 2,734 2,973 2,975 8,681 2,987 3,140 2,803 8,929 2,982 11,911 6 % -3 % Research and development 1,574 1,664 1,659 4,897 1,907 2,101 1,660 5,668 1,836 7,503 — -14 % Restructuring costs 125 163 376 664 119 155 870 1,144 565 1,709 -57 % -42 % Equity income from affiliates -76 % -31 % Other expense, net 282 201 172 656 157 815 * * Income Before Taxes 2,091 1,891 1,490 5,472 1,550 1,245 1,525 4..." |
|
| 07/29/2014 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces Second-Quarter 2014 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF INCOME - GAAP Table 1a 2014 2013 % Change 1Q 2Q June YTD 1Q 2Q June YTD 3Q 4Q Full Year 2Q June YTD . Sales $ 10,264 $ 10,934 $ 21,198 $ 10,671 $ 11,010 $ 21,681 $ 11,032 $ 11,319 $ 44,033 -1 % -2 % Costs, Expenses and Other Materials and production 3,903 4,893 8,796 3,959 4,284 8,243 4,104 4,607 16,954 14 % 7 % Marketing and administrative 2,734 2,973 5,707 2,987 3,140 6,126 2,803 2,982 11,911 -5 % -7 % Research and development 1,574 1,664 3,238 1,907 2,101 4,008 1,660 1,836 7,503 -21 % -19 % Restructuring costs 125 163 288 119 155 274 870 565 1,709 5 % 5 % Equity income from affiliates -21 % -13 % Other expense, net 282 201 484 172 157 815 * * Income Before Taxes 2,091 1,891 3,982 1,550 1,245 2,795 1,525 1,225 5,545 52 % 42 % Income Tax P..." |
|
| 04/29/2014 |
8-K
| Quarterly results|
Docs:
|
"Merck Announces First-Quarter 2014 Financial Results",
"MERCK & CO., INC. CONSOLIDATED STATEMENT OF OPERATIONS - GAAP Table 1a 2014 2013 % Change 1Q 1Q 2Q 3Q 4Q Full Year 1Q Sales $ 10,264 $ 10,671 $ 11,010 $ 11,032 $ 11,319 $ 44,033 -4 % Costs, Expenses and Other Materials and production 3,903 3,959 4,284 4,104 4,607 16,954 -1 % Marketing and administrative 2,734 2,987 3,140 2,803 2,982 11,911 -8 % Research and development 1,574 1,907 2,101 1,660 1,836 7,503 -17 % Restructuring costs 125 119 155 870 565 1,709 5 % Equity income from affiliates -7 % Other expense, net 282 201 172 157 815 * Income Before Taxes 2,091 1,550 1,245 1,525 1,225 5,545 35 % Income Tax Provision 360 310 375 410 1,028 Net Income 1,731 1,616 935 1,150 815 4,517 7 % Less: Net Income Attributable to Noncontrolling Interests 26 23 29 26 34 113 Net Income Attributable to M..." |
|
|
|
|